Industry: Healthcare | Lastest Edition: February 26, 2026 | No of Pages: 142 | No. of Tables: 107 | No. of Figures: 57 | Format: PDF | Report Code : HC1268
The China Dialysis Market size was valued at USD 12.16 billion in 2024 and is expected to reach USD 14.24 billion by 2025. Looking ahead, the market is projected to expand rapidly, reaching USD 22.65 billion by 2030 at a CAGR of 9.73% from 2025 to 2030.
The market is witnessing robust growth due to the increasing prevalence of chronic kidney disease (CKD), diabetes, and hypertension, compounded by rapid urbanization and lifestyle-related risk factors. Innovations in hemodialysis and peritoneal dialysis technologies are enhancing treatment efficacy and patient comfort, while government initiatives and expansion of public healthcare infrastructure are improving accessibility to dialysis services nationwide. Additionally, the growing adoption of home-based dialysis therapies, supported by telehealth platforms, is further accelerating market growth, offering patients greater convenience, flexible treatment options, and improved overall care efficiency across China.
Technological innovation is a major driver of market in China. Automated and connected dialysis machines with real-time monitoring capabilities enhance treatment accuracy, patient safety, and comfort. Integration with telehealth platforms allows clinicians to remotely monitor and manage treatments efficiently. Collaboration between hospitals, medtech companies, and research institutions is fostering innovation in wearable dialysis devices and AI-assisted systems. These advancements are increasing patient adoption, optimizing outcomes, and sustaining the rapid growth of China’s dialysis market.
The rising adoption of home-based dialysis in China is contributing significantly to market growth. Telehealth-enabled remote monitoring allows clinicians to supervise patient treatment in real time, optimize schedules, and prevent complications. Government reimbursement programs and awareness campaigns are promoting broader adoption, especially in urban and semi-urban areas. Home-based dialysis improves convenience and quality of life for patients while reducing hospital burden, driving demand for portable, user-friendly dialysis machines and supporting the expansion of the overall dialysis market in the country.
The high cost of advanced dialysis equipment and infrastructure limitations, especially in rural areas, restrict market expansion. Establishing fully equipped dialysis centers requires substantial investment, while smaller clinics may struggle to adopt modern automated and connected systems. These financial and logistical constraints slow the widespread adoption of advanced technologies, limiting access for some patient populations and constraining the overall growth potential of the market.
The increasing integration of digital health and telemonitoring technologies presents significant market opportunities in China. Remote patient monitoring, smart dialysis systems, and connected devices enable clinicians to deliver more precise care and early interventions. Government initiatives supporting healthcare digitization, combined with private sector innovation, are promoting the development of user-friendly and efficient dialysis solutions. These advancements enhance treatment outcomes, operational efficiency, and patient satisfaction, creating new avenues for market growth and technological differentiation in China’s dialysis sector.
The market players operating in the industry include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Diaverum Deutschland GmbH, Nipro Corporation, B. Braun, Asahi Kasei Corporation, Shandong Weigao Blood Purification Products Co., Ltd., Becton, Dickinson and Company, Nikkiso Co. Ltd., Toray Medical Co., Ltd., Terumo Corporation, and JMS Co. Ltd., and Others.
Hemodialysis (HD)
Hemodialysis Machines
In-center HD
Home HD
Water Treatment Systems
Central water-disinfection units
Point-of-use/portable systems
Ancillary/Other HD Equipment
UF/ultrafiltration pumps
Dialysis chairs/beds
Disinfection/sterilization units
Monitoring & data-capture hardware
HD Consumables & Supplies
Dialyzers
Bloodlines & Tubing Sets
Dialysis Fluids / Concentrates
Vascular Access Products
Other HD Consumables & Accessories
HD Aftermarket Services
Repair & Maintenance
Installation & Commissioning
Training & Technical Support
Peritoneal Dialysis (PD)
PD Cyclers / Automated PD Machines
Ancillary PD Equipment
PD Consumables & Supplies
PD Dialysis Solutions
PD Catheters & Access Systems
Transfer Sets & Tubing
Other PD Supplies / Accessories
PD Aftermarket Services
Repair & Maintenance (Cyclers & Heaters)
Installation & Commissioning
Training & Technical Support
Hospitals
Dialysis Centers
Homecare
Ambulatory Surgical Centers
Diaverum Deutschland GmbH
Nipro Corporation
B Braun
Asahi Kasei Corporation
Shandong Weigao Blood Purification Products Co., Ltd.
Becton, Dickinson and Company.
Nikkiso Co. Ltd.
Toray Medical Co, Ltd.
Terumo Corporation
JMS Co. Ltd.
W. L. Gore & Associates, Inc.
Teleflex Incorporated
Quanta Dialysis Technologies Ltd
|
Parameters |
Details |
|
Market Size in 2025 |
USD 14.24 Billion |
|
Revenue Forecast in 2030 |
USD 22.65 Billion |
|
Growth Rate |
CAGR of 9.73% from 2025 to 2030 |
|
Analysis Period |
2024–2030 |
|
Base Year Considered |
2024 |
|
Forecast Period |
2025–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Growth Factors |
|
|
Companies Profiled |
15 |
|
Market Share |
Available for 10 companies |
|
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
|
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |